{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T08:59:09Z","timestamp":1763369949528,"version":"3.45.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T00:00:00Z","timestamp":1742169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T00:00:00Z","timestamp":1742169600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Rheumatol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Numerous inflammatory complications related to COVID are described, including the Multisystem inflammatory Syndrome in Children (MIS-C) and Hyperinflammation. There is a scarcity of studies comparing these two groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Retrospective longitudinal outcome-conditioned study. Demographic, clinical, and laboratory variables are analyzed. Patients with history of COVID contact or infection with at least 24\u00a0h of fever, two or more systems involved and up to 21 years were included. Patients with no laboratory signal of inflammation or with other diagnoses for the condition were excluded. Demographic and laboratory data are presented as medians with interquartile ranges. Dichotomous variables and prevalences are reported as percentages. A ROC curve analysis was conducted to assess the discriminatory ability of these tests in relation to the MIS-C and hyperinflammation groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      We present fifty-four patients, thirty-one with MIS-C and twenty-three with hyperinflammation. The most frequent symptom in the MIS-C group was altered mental status in 61% vs. 46% (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.014) and conjunctival hyperemia in 29% vs. 4% (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.032). The most frequent laboratory findings were hypoalbuminemia in 68% vs. 26% (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.002), increased serum troponin in 42% vs. 26% (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.034), increased d-dimers in 94% vs. 76% (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.015), as well as increased BNP in 55% vs. 17% (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.02). On the other hand, the hyperinflammation group more frequently presented respiratory dysfunction in 57% vs. 13% (p\u2009=\u2009&lt;\u20090.001) and serum ferritin equal or greater than 500 ng\/mL in 94% vs. 77% (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.046).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This is an original study comparing clinical and laboratory findings between MIS-C and hyperinflammation due to COVID. Altered mental status is more frequently associated with MIS-C while respiratory symptoms are associated with hyperinflammation. In addition, regarding laboratory tests, there is hypoalbuminemia, increase in serum troponin, BNP, and D-dimers specially in the MIS-C group and hyperferritinemia in the hyperinflammation group. Further studies are needed to assess the cutoff point of biological markers such as BNP, troponin, and d-dimers for diagnosis and\/or prognosis in the pediatric population with MIS-C.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s42358-025-00447-6","type":"journal-article","created":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T13:00:16Z","timestamp":1742216416000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical and laboratory markers defining MIS-C and hyperinflammation in COVID-19: a cross-sectional study in a tertiary hospital"],"prefix":"10.1186","volume":"65","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9792-2604","authenticated-orcid":false,"given":"Ana Paula Rad\u00fcnz","family":"Vieira","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4197-3541","authenticated-orcid":false,"given":"Paulo Roberto Antonaccio","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6142-2934","authenticated-orcid":false,"given":"Sandra Helena","family":"Machado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7849-8732","authenticated-orcid":false,"given":"Ta\u00eds Sica","family":"da Rocha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,17]]},"reference":[{"issue":"3","key":"447_CR1","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s12519-020-00343-7","volume":"16","author":"K Shen","year":"2020","unstructured":"Shen K, Yang Y, Wang T, et al. Diagnosis, treatment, and prevention of 2019 novel coronavirus infection in children: experts\u2019 consensus statement. World J Pediatr. 2020;16(3):223\u201331. https:\/\/doi.org\/10.1007\/s12519-020-00343-7.","journal-title":"World J Pediatr"},{"issue":"5","key":"447_CR2","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1097\/INF.0000000000002660","volume":"39","author":"P Zimmermann","year":"2020","unstructured":"Zimmermann P, Curtis N. Coronavirus infections in children including COVID-19: An overview of the epidemiology, clinical features, diagnosis, treatment and prevention options in children. Pediatr Infect Dis J. 2020;39(5):355\u201368. https:\/\/doi.org\/10.1097\/INF.0000000000002660.","journal-title":"Pediatr Infect Dis J"},{"key":"447_CR3","doi-asserted-by":"publisher","unstructured":"Nakra NA, Blumberg DA, Herrera-Guerra A, Lakshminrusimha S. Multi-system inflammatory syndrome in children (MIS-C) following SARS-CoV-2 infection: Review of clinical presentation, hypothetical pathogenesis, and proposed management. Children (Basel). 2020;7(7):69. Published 2020 Jul 1. https:\/\/doi.org\/10.3390\/children7070069","DOI":"10.3390\/children7070069"},{"issue":"10237","key":"447_CR4","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1016\/S0140-6736(20)31094-1","volume":"395","author":"S Riphagen","year":"2020","unstructured":"Riphagen S, Gomez X, Gonzalez-Martinez C, Wilkinson N, Theocharis P. Hyperinflammatory shock in children during COVID-19 pandemic. Lancet. 2020;395(10237):1607\u20138. https:\/\/doi.org\/10.1016\/S0140-6736(20)31094-1.","journal-title":"Lancet"},{"key":"447_CR5","doi-asserted-by":"publisher","first-page":"e13","DOI":"10.1002\/art.41616","volume":"73","author":"LA Henderson","year":"2021","unstructured":"Henderson LA, Canna SW, Friedman KG, et al. American college of rheumatology clinical guidance for multisystem inflammatory syndrome in children associated with SARS-CoV-2 and hyperinflammation in pediatric COVID-19: version 2. Arthritis Rheumatol. 2021;73:e13\u201329. https:\/\/doi.org\/10.1002\/art.41616.","journal-title":"Arthritis Rheumatol"},{"issue":"10239","key":"447_CR6","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1016\/S0140-6736(20)31103-X","volume":"395","author":"L Verdoni","year":"2020","unstructured":"Verdoni L, Mazza A, Gervasoni A, et al. An outbreak of severe Kawasaki-like disease at the Italian epicenter of the SARS-CoV-2 epidemic: An observational cohort study. Lancet. 2020;395(10239):1771\u20138. https:\/\/doi.org\/10.1016\/S0140-6736(20)31103-X.","journal-title":"Lancet"},{"issue":"4","key":"447_CR7","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1056\/NEJMoa2021680","volume":"383","author":"LR Feldstein","year":"2020","unstructured":"Feldstein LR, Rose EB, Horwitz SM, et al. Multisystem inflammatory syndrome in U.S. Children and adolescents. N Engl J Med. 2020;383(4):334\u201346. https:\/\/doi.org\/10.1056\/NEJMoa2021680.","journal-title":"N Engl J Med"},{"issue":"6","key":"447_CR8","doi-asserted-by":"publisher","first-page":"e20200702","DOI":"10.1542\/peds.2020-0702","volume":"145","author":"Y Dong","year":"2020","unstructured":"Dong Y, Mo X, Hu Y, et al. Epidemiology of COVID-19 among children in China. Pediatrics. 2020;145(6):e20200702. https:\/\/doi.org\/10.1542\/peds.2020-0702.","journal-title":"Pediatrics"},{"issue":"3","key":"447_CR9","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1001\/jama.2020.10369","volume":"324","author":"E Whittaker","year":"2020","unstructured":"Whittaker E, Bamford A, Kenny J, et al. Clinical characteristics of 58 children with a pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2. JAMA. 2020;324(3):259\u201369. https:\/\/doi.org\/10.1001\/jama.2020.10369.","journal-title":"JAMA"},{"issue":"3","key":"447_CR10","doi-asserted-by":"publisher","first-page":"e20201766","DOI":"10.1542\/peds.2020-1766","volume":"146","author":"S Gonz\u00e1lez-Dambrauskas","year":"2020","unstructured":"Gonz\u00e1lez-Dambrauskas S, V\u00e1squez-Hoyos P, Camporesi A, et al. Pediatric critical care and COVID-19. Pediatrics. 2020;146(3):e20201766. https:\/\/doi.org\/10.1542\/peds.2020-1766.","journal-title":"Pediatrics"},{"key":"447_CR11","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.jocn.2020.04.062","volume":"76","author":"Z Sedaghat","year":"2020","unstructured":"Sedaghat Z, Karimi N. Guillain Barre syndrome associated with COVID-19 infection: A case report. J Clin Neurosci. 2020;76:233\u20135. https:\/\/doi.org\/10.1016\/j.jocn.2020.04.062.","journal-title":"J Clin Neurosci"},{"issue":"10","key":"447_CR12","doi-asserted-by":"publisher","first-page":"e202430","DOI":"10.1001\/jamapediatrics.2020.2430","volume":"174","author":"P Zachariah","year":"2020","unstructured":"Zachariah P, Johnson CL, Halabi KC, et al. Epidemiology, clinical features, and disease severity in patients with coronavirus disease 2019 (COVID-19) in a children\u2019s hospital in New York City. JAMA Pediatr. 2020;174(10):e202430. https:\/\/doi.org\/10.1001\/jamapediatrics.2020.2430.","journal-title":"JAMA Pediatr"},{"issue":"11","key":"447_CR13","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1007\/s11886-021-01602-3","volume":"23","author":"EY Wu","year":"2021","unstructured":"Wu EY, Campbell MJ. Cardiac manifestations of multisystem inflammatory syndrome in children (MIS-C) following COVID-19. Curr Cardiol Rep. 2021;23(11):168. https:\/\/doi.org\/10.1007\/s11886-021-01602-3. Published 2021 Oct 1.","journal-title":"Curr Cardiol Rep"},{"issue":"4","key":"447_CR14","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1002\/art.42062","volume":"74","author":"LA Henderson","year":"2022","unstructured":"Henderson LA, Canna SW, Friedman KG, et al. American college of rheumatology clinical guidance for multisystem inflammatory syndrome in children associated with SARS-CoV-2 and hyperinflammation in pediatric COVID-19: version 3. Arthritis Rheumatol. 2022;74(4):e1\u201320. https:\/\/doi.org\/10.1002\/art.42062.","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"447_CR15","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s11302-021-09814-6","volume":"18","author":"D Hasan","year":"2022","unstructured":"Hasan D, Shono A, van Kalken CK, van der Spek PJ, Krenning EP, Kotani T. A novel definition and treatment of hyperinflammation in COVID-19 based on purinergic signalling. Purinergic Signal. 2022;18(1):13\u201359. https:\/\/doi.org\/10.1007\/s11302-021-09814-6.","journal-title":"Purinergic Signal"},{"key":"447_CR16","unstructured":"AAP (American Academy of Pediatrics). Multisystem inflammatory syndrome in children (MIS-C) Interim guidance. https:\/\/www.aap.org\/en\/pages\/2019-novel-coronavirus-covid-19-infections\/clinical-guidance\/multisystem-inflammatory-syndrome-in-children-mis-c-interim-guidance (2022) Accessed 1 Feb 2022."},{"issue":"3","key":"447_CR17","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.jped.2020.10.008","volume":"97","author":"F Lima-Setta","year":"2021","unstructured":"Lima-Setta F, Magalh\u00e3es-Barbosa MC, Rodrigues-Santos G, et al. Multisystem inflammatory syndrome in children (MIS-C) during SARS-CoV-2 pandemic in Brazil: a multicenter, prospective cohort study. J Pediatr (Rio J). 2021;97(3):354\u201361. https:\/\/doi.org\/10.1016\/j.jped.2020.10.008.","journal-title":"J Pediatr (Rio J)"},{"issue":"1","key":"447_CR18","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1136\/bmjnph-2021-000375","volume":"5","author":"W Sawadogo","year":"2022","unstructured":"Sawadogo W, Tsegaye M, Gizaw A, Adera T. Overweight and obesity as risk factors for COVID-19-associated hospitalisations and death: Systematic review and meta-analysis. BMJ Nutr Prev Health. 2022;5(1):10\u20138. https:\/\/doi.org\/10.1136\/bmjnph-2021-000375. Published 2022 Jan 19.","journal-title":"BMJ Nutr Prev Health"},{"issue":"1","key":"447_CR19","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1186\/s12887-021-02974-9","volume":"21","author":"L Acevedo","year":"2021","unstructured":"Acevedo L, Pi\u00f1eres-Olave BE, Ni\u00f1o-Serna LF, et al. Mortality and clinical characteristics of multisystem inflammatory syndrome in children (MIS-C) associated with covid-19 in critically ill patients: An observational multicenter study (MISCO study). BMC Pediatr. 2021;21(1):516. https:\/\/doi.org\/10.1186\/s12887-021-02974-9. Published 2021 Nov 18.","journal-title":"BMC Pediatr"},{"issue":"8","key":"447_CR20","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1080\/10408363.2018.1529734","volume":"55","author":"J Favresse","year":"2018","unstructured":"Favresse J, Lippi G, Roy PM, et al. D-dimer: Preanalytical, analytical, postanalytical variables, and clinical applications. Crit Rev Clin Lab Sci. 2018;55(8):548\u201377. https:\/\/doi.org\/10.1080\/10408363.2018.1529734.","journal-title":"Crit Rev Clin Lab Sci"},{"issue":"4","key":"447_CR21","doi-asserted-by":"publisher","first-page":"660","DOI":"10.36660\/abc.20200385","volume":"115","author":"GLG Almeida Junior","year":"2020","unstructured":"Almeida Junior GLG, Braga F, Jorge JK, et al. Prognostic value of Troponin-T and B-Type natriuretic peptide in patients hospitalized for COVID-19. Valor Progn\u00f3stico da Troponina T e do Pept\u00eddeo Natriur\u00e9tico Tipo B em Pacientes Internados por COVID-19. Arq Bras Cardiol. 2020;115(4):660\u20136. https:\/\/doi.org\/10.36660\/abc.20200385.","journal-title":"Arq Bras Cardiol"},{"key":"447_CR22","doi-asserted-by":"publisher","first-page":"944743","DOI":"10.3389\/fped.2022.944743","volume":"10","author":"S Trapani","year":"2022","unstructured":"Trapani S, Rubino C, Lasagni D, et al. Thromboembolic complications in children with COVID-19 and MIS-C: A narrative review. Front Pediatr. 2022;10:944743. https:\/\/doi.org\/10.3389\/fped.2022.944743. Published 2022 Aug 11.","journal-title":"Front Pediatr"},{"issue":"11","key":"447_CR23","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1055\/a-1400-6034","volume":"121","author":"S Hammer","year":"2021","unstructured":"Hammer S, H\u00e4berle H, Schlensak C, et al. Severe SARS-CoV-2 infection inhibits fibrinolysis leading to changes in viscoelastic properties of blood clot: A descriptive study of fibrinolysis in COVID-19. Thromb Haemost. 2021;121(11):1417\u201326. https:\/\/doi.org\/10.1055\/a-1400-6034.","journal-title":"Thromb Haemost"},{"key":"447_CR24","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.thromres.2020.08.030","volume":"196","author":"DJ Hoechter","year":"2020","unstructured":"Hoechter DJ, Becker-Pennrich A, Langrehr J, et al. Higher procoagulatory potential but lower DIC score in COVID-19 ARDS patients compared to non-COVID-19 ARDS patients. Thromb Res. 2020;196:186\u201392. https:\/\/doi.org\/10.1016\/j.thromres.2020.08.030.","journal-title":"Thromb Res"},{"key":"447_CR25","doi-asserted-by":"publisher","first-page":"829420","DOI":"10.3389\/fped.2022.829420","volume":"10","author":"MM Kostik","year":"2022","unstructured":"Kostik MM, Bregel LV, Avrusin IS, et al. Heart involvement in multisystem inflammatory syndrome, associated with COVID-19 in children: The retrospective multicenter cohort data. Front Pediatr. 2022;10:829420. https:\/\/doi.org\/10.3389\/fped.2022.829420.","journal-title":"Front Pediatr"}],"container-title":["Advances in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42358-025-00447-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s42358-025-00447-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42358-025-00447-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T08:55:08Z","timestamp":1763369708000},"score":1,"resource":{"primary":{"URL":"https:\/\/advancesinrheumatology.biomedcentral.com\/articles\/10.1186\/s42358-025-00447-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,17]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["447"],"URL":"https:\/\/doi.org\/10.1186\/s42358-025-00447-6","relation":{},"ISSN":["2523-3106"],"issn-type":[{"type":"electronic","value":"2523-3106"}],"subject":[],"published":{"date-parts":[[2025,3,17]]},"assertion":[{"value":"1 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics Committee of Research at the Federal University of Rio Grande do Sul (CAAE 38059720.6.0000.5327). Subjects were included in the study after an informed consent form was signed by the children representative. Informed assent was collected from children over 6 years old. All authors agreed on a data usage commitment policy. All authors approved the definitive version of manuscript and agreement in ensuring that questions related to the data accuracy and integrity are appropriately investigated and resolved.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"We assure that the data presented here was not published elsewhere and the article has not been submitted to any other journal. We give our consent for the publication of the manuscript \u201cClinical and laboratory markers defining MIS-C and Hyperinflammation in COVID-19: A Cross sectional study in a tertiary hospital\u201d.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"16"}}